Assay Development in vivo and in vitro
TFBS provides a wide range of services to support assay development from early drug discovery, preclinical development, to clinical stage. Our scientists support assay development to investigate drug potency related activity in vitro and in vivo at different stages, such as assay development, optimization, and validation. Various assay types include
ELISA and ECL
- Anti-drug antibody (ADA) assay
- Biomarker measurement
- Cytokine profiling
Cell-based Assays
- Potency assay
- Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
- Complement Dependent Cytotoxicity (CDC) assays
- Antiviral activity assay
- Neutralization assay
- FACS
- Tissue Cross Reactivity
Animal Study
- Pharmacokinetic (PK)
- Toxicokinetic (TK)
- Biodistribution
- Disease models
Customized Solution
- Development
- Validation
- Method Transfer
- Preclinical and Clinical Samples Analysis (GLP/GMP)
- Bulk Lot Release Testing (GMP)
TFBS also offers customized solutions in all stages of drug development and clinical sample analysis. Our team will collaborate with you to meet your requirement for assay development. We ensure you with high quality in a time-sensitive manner for bioassay development and validation.